LAROSA JOSEPH J
Insider CIK 1238303 · REGN SVP General Counsel and Secret
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2026-08-19 | 2026-08-21 | 12,282 | — | $0 | 12,283 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2026-08-19 | 2026-08-21 | 12,282 | $381.92 | $4.69M | 45,392 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2026-08-19 | 2026-08-21 | 9,019 | $830.15 | $7.49M | 36,373 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2026-08-19 | 2026-08-21 | 12,282 | — | $0 | 12,283 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2026-08-19 | 2026-08-21 | 9,019 | $830.15 | $7.49M | 36,373 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2026-08-19 | 2026-08-21 | 12,282 | $381.92 | $4.69M | 45,392 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-08 | 2025-12-09 | 1,396 | $712.94 | $995.3K | 29,517 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-12-05 | 2025-12-09 | 12,210 | — | $0 | 12,210 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-12-05 | 2025-12-09 | 2,476 | — | $0 | 30,913 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2025-11-20 | 2025-11-24 | 14,450 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2025-11-20 | 2025-11-24 | 14,450 | $555.67 | $8.03M | 35,525 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-11-20 | 2025-11-24 | 12,686 | $736.77 | $9.35M | 22,839 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-12-16 | 2024-12-18 | 702 | $730.81 | $513.0K | 30,075 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-10 | 492 | $787.00 | $387.2K | 30,777 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-12-06 | 2024-12-10 | 8,981 | — | $0 | 8,981 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-12-06 | 2024-12-10 | 2,332 | — | $0 | 31,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-07-11 | 2024-07-12 | 1,866 | $1088.95 | $2.03M | 37,937 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-06-24 | 2024-06-25 | 14,450 | — | $0 | 14,450 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-06-24 | 2024-06-25 | 14,450 | $555.67 | $8.03M | 50,887 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-06-24 | 2024-06-25 | 11,084 | $1060.13 | $11.75M | 39,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | G Gift | 2024-06-10 | 2024-06-12 | 1,608 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-21 | 2024-05-22 | 1,865 | $994.90 | $1.86M | 34,678 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-26 | 2024-02-28 | 1,000 | $990.00 | $990.0K | 36,543 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-22 | 2024-02-26 | 1,000 | $967.65 | $967.6K | 37,543 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-07 | 2024-02-09 | 1,000 | $950.00 | $950.0K | 38,543 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-01-03 | 2024-01-04 | 34,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-01-03 | 2024-01-04 | 24,493 | $912.30 | $22.34M | 39,543 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-01-03 | 2024-01-04 | 34,000 | $399.66 | $13.59M | 64,036 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-11 | 2023-12-12 | 669 | $844.09 | $564.7K | 30,036 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 7,649 | — | $0 | 7,649 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-12-08 | 2023-12-12 | 2,133 | — | $0 | 30,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-08 | 2023-12-12 | 852 | $843.79 | $718.9K | 28,572 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-03-23 | 2023-03-27 | 10,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-03-23 | 2023-03-27 | 6,742 | $801.59 | $5.40M | 27,471 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-03-23 | 2023-03-27 | 10,000 | $270.43 | $2.70M | 34,213 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | G Gift | 2023-03-10 | 2023-03-14 | 1,006 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-12-16 | 2022-12-20 | 10,159 | — | $0 | 10,159 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-12-16 | 2022-12-20 | 2,752 | — | $0 | 23,110 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-12-09 | 2022-12-13 | 492 | $753.28 | $370.6K | 20,358 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-09 | 2022-09-12 | 30,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-09-09 | 2022-09-12 | 20,730 | $730.96 | $15.15M | 20,850 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-09 | 2022-09-12 | 30,000 | $270.43 | $8.11M | 41,580 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-07 | 2022-04-11 | 5,114 | $721.10 | $3.69M | 16,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 250 | $690.51 | $172.6K | 24,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 641 | $691.44 | $443.2K | 23,797 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 259 | $694.56 | $179.9K | 22,776 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 305 | $695.36 | $212.1K | 22,471 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 254 | $696.54 | $176.9K | 22,217 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 497 | $687.41 | $341.6K | 25,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 124 | $698.26 | $86.6K | 22,029 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 15 | $701.82 | $10.5K | 22,014 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 195 | $692.54 | $135.0K | 23,602 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 567 | $693.92 | $393.5K | 23,035 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 369 | $685.71 | $253.0K | 26,759 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 557 | $686.26 | $382.2K | 26,202 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 218 | $689.43 | $150.3K | 24,688 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 799 | $688.59 | $550.2K | 24,906 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-01 | 2022-04-04 | 64 | $697.35 | $44.6K | 22,153 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-12-11 | 2021-12-14 | 697 | $664.34 | $463.0K | 26,051 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-12-09 | 2021-12-10 | 30,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-12-09 | 2021-12-10 | 19,772 | $657.11 | $12.99M | 26,748 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-12-09 | 2021-12-10 | 30,000 | $179.13 | $5.37M | 46,520 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-12-08 | 2021-12-10 | 14,253 | — | $0 | 14,253 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-12-08 | 2021-12-10 | 3,338 | — | $0 | 16,520 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-23 | 2021-08-24 | 1 | $666.22 | $666 | 13,182 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-23 | 2021-08-24 | 41 | $665.40 | $27.3K | 13,183 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-23 | 2021-08-24 | 3,383 | $661.80 | $2.24M | 13,224 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-20 | 2021-08-24 | 10,000 | — | $0 | 30,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-20 | 2021-08-24 | 10,000 | $179.13 | $1.79M | 23,182 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-08-20 | 2021-08-24 | 6,575 | $664.85 | $4.37M | 16,607 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-07-06 | 2021-07-07 | 3,398 | $580.00 | $1.97M | 13,182 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-07-02 | 2021-07-07 | 10,000 | — | $0 | 40,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-07-02 | 2021-07-07 | 10,000 | $179.13 | $1.79M | 23,182 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-07-02 | 2021-07-07 | 6,602 | $582.20 | $3.84M | 16,580 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-12-09 | 2020-12-11 | 19,950 | — | $0 | 19,950 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-12-09 | 2020-12-11 | 1,930 | — | $0 | 16,368 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-31 | 2020-08-31 | 4,672 | $615.04 | $2.87M | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-08-27 | 2020-08-31 | 4,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-08-27 | 2020-08-31 | 6,000 | — | $0 | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-08-27 | 2020-08-31 | 2,131 | $614.87 | $1.31M | 19,110 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-08-27 | 2020-08-31 | 4,000 | $52.03 | $208.1K | 21,241 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-08-27 | 2020-08-31 | 6,000 | $52.03 | $312.2K | 20,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-08-27 | 2020-08-31 | 3,197 | $614.87 | $1.97M | 17,241 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-15 | 2020-05-15 | 8,380 | $572.00 | $4.79M | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-15 | 18,311 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-05-14 | 2020-05-15 | 9,931 | $573.18 | $5.69M | 22,818 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-15 | 18,311 | $59.20 | $1.08M | 32,749 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 1,189 | $566.44 | $673.5K | 16,216 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 1,468 | $565.60 | $830.3K | 17,405 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 377 | $564.74 | $212.9K | 18,873 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 416 | $563.58 | $234.4K | 19,250 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 21 | $562.71 | $11.8K | 19,666 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 51 | $561.57 | $28.6K | 19,687 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 577 | $573.59 | $331.0K | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 61 | $572.94 | $34.9K | 15,015 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 112 | $571.65 | $64.0K | 15,076 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 125 | $570.27 | $71.3K | 15,188 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 234 | $569.41 | $133.2K | 15,313 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-20 | 2020-04-20 | 669 | $567.30 | $379.5K | 15,547 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-17 | 2020-04-20 | 6,622 | — | $0 | 23,311 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-17 | 2020-04-20 | 5,000 | — | $0 | 18,311 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 191 | $562.56 | $107.4K | 14,796 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 285 | $559.79 | $159.5K | 15,213 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 293 | $558.55 | $163.7K | 15,498 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 93 | $557.40 | $51.8K | 15,791 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 198 | $556.51 | $110.2K | 15,884 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 114 | $555.10 | $63.3K | 16,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 104 | $552.85 | $57.5K | 16,196 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 6 | $550.00 | $3.3K | 16,300 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 100 | $549.24 | $54.9K | 16,306 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 99 | $548.27 | $54.3K | 16,406 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 100 | $547.00 | $54.7K | 16,505 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 5 | $542.31 | $2.7K | 16,605 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 95 | $541.94 | $51.5K | 16,610 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-17 | 2020-04-20 | 2,720 | $555.82 | $1.51M | 19,738 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-17 | 2020-04-20 | 5,000 | $59.20 | $296.0K | 22,458 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-17 | 2020-04-20 | 3,602 | $555.82 | $2.00M | 17,458 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-17 | 2020-04-20 | 6,622 | $59.20 | $392.0K | 21,060 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 94 | $565.92 | $53.2K | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 93 | $564.19 | $52.5K | 14,532 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 171 | $563.39 | $96.3K | 14,625 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 163 | $560.38 | $91.3K | 15,050 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-17 | 2020-04-20 | 63 | $561.76 | $35.4K | 14,987 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-16 | 2020-04-20 | 5,000 | — | $0 | 29,933 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-16 | 2020-04-20 | 2,733 | $529.79 | $1.45M | 16,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-16 | 2020-04-20 | 5,000 | $59.20 | $296.0K | 19,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 499 | $518.25 | $258.6K | 15,169 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 6 | $525.30 | $3.2K | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 106 | $524.99 | $55.6K | 14,444 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 113 | $521.05 | $58.9K | 14,550 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 220 | $520.45 | $114.5K | 14,663 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 286 | $519.43 | $148.6K | 14,883 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 266 | $517.40 | $137.6K | 15,668 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 260 | $516.81 | $134.4K | 15,934 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 414 | $515.70 | $213.5K | 16,194 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-15 | 2020-04-16 | 92 | $514.63 | $47.3K | 16,608 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-14 | 2020-04-16 | 5,000 | — | $0 | 34,933 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-14 | 2020-04-16 | 5,000 | $59.20 | $296.0K | 19,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-14 | 2020-04-16 | 2,738 | $521.45 | $1.43M | 16,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 100 | $497.32 | $49.7K | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 210 | $496.50 | $104.3K | 14,538 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 321 | $495.19 | $159.0K | 14,748 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 111 | $494.36 | $54.9K | 15,069 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 652 | $493.35 | $321.7K | 15,180 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 521 | $492.62 | $256.7K | 15,832 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 450 | $491.42 | $221.1K | 16,353 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 484 | $490.32 | $237.3K | 16,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 734 | $489.72 | $359.5K | 17,287 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 1,626 | $488.26 | $793.9K | 18,021 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 470 | $487.71 | $229.2K | 19,647 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 485 | $486.61 | $236.0K | 20,117 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 441 | $485.65 | $214.2K | 20,602 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-04-02 | 2020-04-03 | 192 | $484.58 | $93.0K | 21,043 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-01 | 2020-04-03 | 5,000 | — | $0 | 39,933 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-01 | 2020-04-03 | 5,000 | — | $0 | 49,933 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-04-01 | 2020-04-03 | 5,000 | — | $0 | 44,933 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-01 | 2020-04-03 | 2,757 | $488.22 | $1.35M | 18,924 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-01 | 2020-04-03 | 5,000 | $59.20 | $296.0K | 21,681 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-01 | 2020-04-03 | 2,757 | $488.22 | $1.35M | 16,681 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-01 | 2020-04-03 | 5,000 | $59.20 | $296.0K | 23,924 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-04-01 | 2020-04-03 | 5,000 | $59.20 | $296.0K | 19,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-04-01 | 2020-04-03 | 2,689 | $488.22 | $1.31M | 21,235 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2019-12-11 | 2019-12-13 | 24,500 | — | $0 | 24,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2019-12-11 | 2019-12-13 | 2,625 | — | $0 | 14,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-12-12 | 2018-12-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-12-12 | 2017-12-13 | 23,337 | — | $0 | 23,337 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-12-16 | 2016-12-19 | 24,565 | — | $0 | 24,565 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2016-09-01 | 2016-09-02 | 4,943 | $392.63 | $1.94M | 11,813 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-12-16 | 2015-12-18 | 28,900 | — | $0 | 28,900 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-09-01 | 2015-09-02 | 1,689 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-09-01 | 2015-09-02 | 1,689 | $59.20 | $100.0K | 16,756 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-03-25 | 2015-03-26 | 3,097 | — | $0 | 1,689 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-03-25 | 2015-03-26 | 3,097 | $59.20 | $183.3K | 15,067 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-03-16 | 2015-03-17 | 1,970 | — | $0 | 4,786 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-03-16 | 2015-03-17 | 18,311 | — | $0 | 54,933 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-03-16 | 2015-03-17 | 18,311 | $59.20 | $1.08M | 28,311 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-03-16 | 2015-03-17 | 1,970 | $59.20 | $116.6K | 11,970 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-03-16 | 2015-03-17 | 18,311 | $450.00 | $8.24M | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-12-16 | 2014-12-18 | 34,000 | — | $0 | 34,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-12-16 | 2014-12-18 | 6,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-12-13 | 2013-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-12-14 | 2012-12-17 | 50,000 | — | $0 | 50,000 | SEC↗ |